Newsroom
Sorted by: Latest
-
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 23.04.2026 FVD. IE00BKVKW020 250,002.00 USD 7,323,004.73 29.292 ...
-
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2026
MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the first quarter ended March 31, 2026. First Quarter Consolidated Results Reported revenue increased 11.1% to $435.8 million in the first quarter of 2026 versus last year’s first quarter results of $392.3 million. On a local currency basis(1), revenue increased 7.2%. Reported operating i...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 23.04.2026 FCSG IE00BKPSPT20 1,025,002.00 USD 43,719,024.61 42.653 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 23.04.2026 FXGB LN IE00BD5HBR05 37,992.00 GBP 764,884.88 27.200 ...
-
Natixis Syndicate UK Regulatory Announcement: Post-stabilisation Announcement
LONDON--(BUSINESS WIRE)-- POST-STABILISATION ANNOUNCEMENT Date: 24th April, 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. European Union Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 14th April 2026, Natixis (Christopher Agathangelou - Syndicate Contact; telephone: +33158550814) hereby gives notice that no stabilisation (within the meaning of A...
-
Kontoor Brands Declares Quarterly Dividend
GREENSBORO, N.C.--(BUSINESS WIRE)--Kontoor Brands, Inc. (NYSE: KTB) today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.53 per share of its common stock. The cash dividend will be payable on June 18, 2026, to shareholders of record at the close of business June 8, 2026. About Kontoor Brands Kontoor Brands, Inc. (NYSE: KTB) is a portfolio of three of the world’s most iconic lifestyle, outdoor and workwear brands: Wrangler®, Lee® and Helly Hansen®. Kon...
-
SLB Announces First-Quarter 2026 Results
HOUSTON--(BUSINESS WIRE)--SLB (NYSE: SLB) today announced results for the first-quarter 2026. First-Quarter Results (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2026 Dec. 31, 2025 Mar. 31, 2025 Sequential Year-on-year Revenue $8,721 $9,745 $8,490 -11% 3% Income before taxes - GAAP basis $956 $943 $1,063 1% -10% Income before taxes margin - GAAP basis 11.0% 9.7% 12.5% 129 bps -156 bps Net income attributable to SLB - GAAP basis $752 $824 $797 -9...
-
Tradr Launches Leveraged ETFs on AXTI, CPNG, MPWR and STX
NEW YORK--(BUSINESS WIRE)--New 200% Leveraged ETFs on AXTI, CPNG, MPWR and STX...
-
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Merck’s pending acquisition of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN) expired at 11:59 p.m., Eastern Time, on April 23, 2026. As previously announced on April 7, 2026, Merck commenced, through a subsidiary, a cash tender offer to purchase...